Of course, it has been believed previously that oral hypoglycemic agents such as Metformin is contraindicated in Type I diabetes patients. But now there are a number of evidences that support its good outcome in Type I DM. I think it might also exhibit a better clinical outcomes and even possible to consider Metformin alone in honey moon period (where~20% of the pancreatic beta cells left).